NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fa

U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares di

SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.03) per share which beat the analyst consen

Mesoblast shares fall after new Ryoncil data show high survival in severe GVHD. Company plans adult

Mesoblast reports early real-world data showing 84% survival in children treated with FDA-approved R

Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, s

Mesoblast reported strong year‑over‑year growth in December quarter sales of its flagship therapy, R

Revenue from cell therapy products was US$20.6 million, up from US$12.9 million in the previous quar

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading